Amantadine is a medication that has U.S. Food and Drug Administration approval for use both as an antiviral and an antiparkinsonian medication.

The global Amantadine HCl Oral market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Amantadine HCl Oral volume and value at global level, regional level and company level. From a global perspective, this report represents overall Amantadine HCl Oral market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Amantadine HCl Oral in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Amantadine HCl Oral manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Zydus Pharmaceuticals
Mylan
Teva
Vertical Pharmaceuticals
Adamas Pharmaceuticals
Upsher-Smith
Sandoz
Mikart Pharmaceuticals
Pharmaceutical Associates, Inc. (PAI)
Wockhardt Bio AG
CMP Pharma
Bionpharma
Graviti Pharma
Alembic Pharmaceuticals
Strides Pharma
Heritage Pharmaceuticals

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Tablet
Capsules
Syrup

Segment by Application
Parkinson's disease
Influenza